BOSTON — Who would have thought it? The quest for eternal life, or at least prolonged youthfulness, has now migrated from the outer fringes of alternative medicine to the halls of Harvard Medical School.
At a conference on aging held here last week, the medical school’s dean, Jeffrey Flier, was to be seen greeting participants who ranged from members of the 120 club (they intend to live at least that long) to devotees of very low calorie diets.
The heavyweight at the conference was Sirtris Pharmaceuticals. The company is developing drugs that mimic resveratrol, a chemical found in some red wines. Resveratrol has been found to activate proteins called sirtuins, from which the company derives its name. Activation of sirtuins is thought to help the body ride out famines.